Status:
COMPLETED
Coronary Drug Project Mortality Surveillance
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
MALE
30-64 years
Phase:
NA
Brief Summary
To determine whether there were any long term sequelae of the drugs used in the Coronary Drug Project (estrogens, dextrothyroxine, nicotinic acid, clofibrate).
Detailed Description
BACKGROUND: Three of the CDP treatments (two doses of estrogen and dextrothyroxine) were stopped prematurely because of toxicity. At the time the treatments were stopped, it was thought that future a...
Eligibility Criteria
No eligibility criteria
Key Trial Info
Start Date :
June 1 1981
Trial Type :
INTERVENTIONAL
End Date :
March 1 1985
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000483
Start Date
June 1 1981
End Date
March 1 1985
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.